Antiphospholipid syndrome and Gastrointestinal inflammation

Summary:

Gastrointestinal inflammation is reported only by a few people with Antiphospholipid syndrome.

The study analyzes which people have Gastrointestinal inflammation with Antiphospholipid syndrome. It is created by eHealthMe based on 2 people who have Gastrointestinal inflammation and Antiphospholipid syndrome from the Food and Drug Administration (FDA), and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Apr, 16, 2022

2 people who have Antiphospholipid Syndrome and Gastrointestinal Inflammation are studied.


What is Antiphospholipid syndrome?

Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss) is found to be associated with 596 drugs and 336 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 759 drugs and 492 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Antiphospholipid syndrome reports submitted per year:

Would you have Gastrointestinal inflammation when you have Antiphospholipid syndrome?

Gender of people who have Antiphospholipid Syndrome and experienced Gastrointestinal Inflammation *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Antiphospholipid Syndrome and experienced Gastrointestinal Inflammation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Rickets (softening of bones): 2 people, 100.00%
  2. Osteoporosis (bones weak and more likely to break): 2 people, 100.00%
  3. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 100.00%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 100.00%

Common drugs taken by these people *:

  1. Warfarin Sodium: 2 people, 100.00%
  2. Prednisolone: 2 people, 100.00%
  3. Methotrexate: 2 people, 100.00%
  4. Clopidogrel: 2 people, 100.00%
  5. Alendronate Sodium: 2 people, 100.00%
  6. Actemra: 2 people, 100.00%
  7. Nexium: 1 person, 50.00%

Common symptoms for these people *:

  1. Pyogenic Liver Abscess (liver abscess caused by bacteria): 2 people, 100.00%
  2. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 100.00%
  3. Liver Disorder (liver diseases): 2 people, 100.00%
  4. Inflammation: 2 people, 100.00%
  5. Gastric Disorder (disease of stomach): 2 people, 100.00%
  6. Bacteraemia (presence of bacteria in the blood): 2 people, 100.00%
  7. Nasopharyngitis (inflammation of the nasopharynx): 1 person, 50.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 50.00%
  9. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study is based on Gastrointestinal inflammation and Antiphospholipid syndrome, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: